scholarly article | Q13442814 |
P50 | author | Alain Fischer | Q2636403 |
Capucine Picard | Q30503757 | ||
Frédéric Rieux-Laucat | Q37645087 | ||
Aude Magerus-Chatinet | Q42325098 | ||
Marie-Claude Stolzenberg | Q45929155 | ||
Bénédicte Neven | Q89742464 | ||
Nina Lanzarotti | Q114516795 | ||
Cécile Daussy | Q114516801 | ||
Nathalie Neveux | Q114516802 | ||
P2093 | author name string | Kanjaksha Ghosh | |
Manisha Madkaikar | |||
Mukesh Desai | |||
Meghana Rao | |||
P2860 | cites work | Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndrome | Q24623046 |
Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease | Q28115268 | ||
Autoimmune lymphoproliferative syndrome with somatic Fas mutations | Q28285625 | ||
FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function | Q28307801 | ||
Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib | Q33289658 | ||
Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity | Q33488225 | ||
The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis | Q33952333 | ||
The many roles of FAS receptor signaling in the immune system | Q34205697 | ||
Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance | Q34389314 | ||
Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation | Q34428954 | ||
Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype | Q34513178 | ||
Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways | Q35091428 | ||
Fas receptor expression in germinal-center B cells is essential for T and B lymphocyte homeostasis | Q36314636 | ||
A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome. | Q36454970 | ||
Fas and Fas ligand: lpr and gld mutations | Q40398275 | ||
Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis | Q44455328 | ||
Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome | Q55670225 | ||
Perforin-dependent apoptosis functionally compensates Fas deficiency in activation-induced cell death of human T lymphocytes | Q57014792 | ||
Chronic lymphadenopathy simulating malignant lymphoma | Q59242110 | ||
Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression | Q73850215 | ||
TcR-alpha/beta(+) CD4(-)CD8(-) T cells in humans with the autoimmune lymphoproliferative syndrome express a novel CD45 isoform that is analogous to murine B220 and represents a marker of altered O-glycan biosynthesis | Q74401877 | ||
Novel Fas (CD95/APO-1) mutations in infants with a lymphoproliferative disorder | Q74418696 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | autoimmune lymphoproliferative syndrome | Q1151300 |
homozygosity | Q114049690 | ||
P1104 | number of pages | 5 | |
P304 | page(s) | 486-490 | |
P577 | publication date | 2012-07-31 | |
P1433 | published in | The Journal of Allergy and Clinical Immunology | Q7743550 |
P1476 | title | Autoimmune lymphoproliferative syndrome caused by a homozygous null FAS ligand (FASLG) mutation | |
P478 | volume | 131 |
Q48283620 | A FAS-ligand variant associated with autoimmune lymphoproliferative syndrome in cats |
Q27027001 | Advances in basic and clinical immunology in 2013 |
Q55297581 | Autoimmune Lymphoproliferative Syndrome-FAS Patients Have an Abnormal Regulatory T Cell (Treg) Phenotype but Display Normal Natural Treg-Suppressive Function on T Cell Proliferation. |
Q41428240 | Decreased activation-induced cell death by EBV-transformed B-cells from a patient with autoimmune lymphoproliferative syndrome caused by a novel FASLG mutation. |
Q36708937 | Deregulation of Fas ligand expression as a novel cause of autoimmune lymphoproliferative syndrome-like disease |
Q55284675 | Fas Ligand localizes to intraluminal vesicles within NK cell cytolytic granules and is enriched at the immune synapse. |
Q92758747 | Fatal Hypogammaglobulinemia 3 Years after Rituximab in a Patient with Immune Thrombocytopenia: An Underlying Genetic Predisposition? |
Q38641601 | Frequency of a FAS ligand gene variant associated with inherited feline autoimmune lymphoproliferative syndrome in British shorthair cats in New Zealand. |
Q38934946 | Serine protease inhibitors interact with IFN-γ through up-regulation of FasR; a novel therapeutic strategy against cancer. |
Q57078448 | The Autoimmune Lymphoproliferative Syndrome with Defective FAS or FAS-Ligand Functions |
Q64882605 | The Role of Efferocytosis in Autoimmune Diseases. |
Q35619447 | The expanding spectrum of the autoimmune lymphoproliferative syndromes |
Search more.